{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:54:43Z","timestamp":1782604483709,"version":"3.54.5"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.path.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T23:49:46Z","timestamp":1604965786000},"page":"601-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pediatric Liver Tumors"],"prefix":"10.1016","volume":"13","author":[{"given":"Soo-Jin","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib2","doi-asserted-by":"crossref","first-page":"pkz007","DOI":"10.1093\/jncics\/pkz007","article-title":"Trends in International Incidence of Pediatric Cancers in Children Under 5 Years of Age: 1988-2012","volume":"3","author":"Hubbard","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib3","first-page":"62","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.path.2020.09.002_bib4","series-title":"Liver diseaase in children","year":"2014"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/pbc.20122","article-title":"Hepatoblastoma and low birth weight","volume":"43","author":"Spector","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.path.2020.09.002_bib7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjc.6604335","article-title":"Perinatal risk factors for hepatoblastoma","volume":"98","author":"Spector","year":"2008","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.2008-3069","article-title":"Cancer risk among children with very low birth weights","volume":"124","author":"Spector","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"Lopez-Terrada","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1093526619875228","article-title":"Hepatoblastoma and pediatric hepatocellular carcinoma: an update","volume":"23","author":"Ranganathan","year":"2020","journal-title":"Pediatr Dev Pathol"},{"issue":"7","key":"10.1016\/j.path.2020.09.002_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000478-198210000-00002","article-title":"Hepatoblastoma. Attempt at characterization of histologic subtypes","volume":"6","author":"Gonzalez-Crussi","year":"1982","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","article-title":"Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups","volume":"65","author":"Sumazin","year":"2017","journal-title":"Hepatology"},{"issue":"7696","key":"10.1016\/j.path.2020.09.002_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Grobner","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","article-title":"Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications","volume":"73","author":"Carrillo-Reixach","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mpo.10177","article-title":"Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin","volume":"39","author":"Prokurat","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/his.13297","article-title":"Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution","volume":"71","author":"Zhou","year":"2017","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"Eichenmuller","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cld.2011.03.011","article-title":"Liver neoplasia in children","volume":"15","author":"Hadzic","year":"2011","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiol.2020200751","article-title":"Pediatric hepatoblastoma, hepatocellular carcinoma, and other hepatic neoplasms: consensus imaging recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group","volume":"296","author":"Schooler","year":"2020","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","article-title":"2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pbc.21834","article-title":"Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors","volume":"52","author":"Trobaugh-Lotrario","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.path.2020.09.002_bib24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/gcc.22390","article-title":"Small cell undifferentiated (SCUD) hepatoblastomas: all malignant rhabdoid tumors?","volume":"55","author":"Vokuhl","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.path.2020.09.002_bib25","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#","article-title":"Small cell undifferentiated histology in hepatoblastoma may be unfavorable","volume":"92","author":"Haas","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.humpath.2014.12.013","article-title":"Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable?","volume":"46","author":"Zhou","year":"2015","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0b013e3181ce5f1e","article-title":"Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study","volume":"34","author":"Wang","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpedsurg.2013.09.050","article-title":"A\u00a0review of 218 pediatric cases of hepatocellular carcinoma","volume":"49","author":"Allan","year":"2014","journal-title":"J\u00a0Pediatr Surg"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpeds.2011.03.004","article-title":"Hepatocellular carcinoma in biliary atresia: King's College Hospital experience","volume":"159","author":"Hadzic","year":"2011","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.path.2020.09.002_bib30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/petr.12781","article-title":"Cause and effect: the etiology of pediatric hepatocellular carcinoma and the role for liver transplantation","volume":"20","author":"O'Neill","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PAP.0b013e3180504913","article-title":"Review of the clinicopathologic features of fibrolamellar carcinoma","volume":"14","author":"Torbenson","year":"2007","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/his.12312","article-title":"Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM","volume":"64","author":"Zen","year":"2014","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2020.09.002_bib34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/lt.24847","article-title":"Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015)","volume":"23","author":"Vinayak","year":"2017","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1148\/radiology.213.2.r99nv31352","article-title":"Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases","volume":"213","author":"Ichikawa","year":"1999","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hep.510260412","article-title":"Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation","volume":"26","author":"Pinna","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2020.09.002_bib37","series-title":"WHO classification of digestive system tumours","year":"2019"},{"issue":"14","key":"10.1016\/j.path.2020.09.002_bib38","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3748\/wjg.v25.i14.1653","article-title":"Update on hepatocellular carcinoma: pathologists' review","volume":"25","author":"El Jabbour","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.gtc.2017.01.009","article-title":"Morphologic subtypes of hepatocellular carcinoma","volume":"46","author":"Torbenson","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"issue":"7","key":"10.1016\/j.path.2020.09.002_bib40","doi-asserted-by":"crossref","first-page":"e27745","DOI":"10.1002\/pbc.27745","article-title":"Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation","volume":"66","author":"Haines","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cld.2015.01.010","article-title":"Hepatocellular carcinoma in children","volume":"19","author":"Kelly","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00428-017-2204-1","article-title":"Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency","volume":"471","author":"Vij","year":"2017","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/1097-0142(19820815)50:4<702::AID-CNCR2820500414>3.0.CO;2-F","article-title":"Ultrastructure of fibrolamellar oncocytic hepatoma","volume":"50","author":"Farhi","year":"1982","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2010.207","article-title":"Fibrolamellar carcinomas are positive for CD68","volume":"24","author":"Ross","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/modpathol.2017.103","article-title":"Molecular testing for the clinical diagnosis of fibrolamellar carcinoma","volume":"31","author":"Graham","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2020.09.002_bib46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/modpathol.2010.105","article-title":"Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation","volume":"23","author":"Ward","year":"2010","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.09.002_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.1711630111","article-title":"'Neuroendocrine' differentiation in primary neoplasms of the liver","volume":"163","author":"Wang","year":"1991","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/modpathol.2016.59","article-title":"Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss","volume":"29","author":"Graham","year":"2016","journal-title":"Mod Pathol"},{"issue":"6174","key":"10.1016\/j.path.2020.09.002_bib49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1249484","article-title":"Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma","volume":"343","author":"Honeyman","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib50","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/j.gastro.2017.09.008","article-title":"CRISPR\/Cas9 engineering of adult mouse liver demonstrates that the dnajb1-prkaca gene fusion is sufficient to induce tumors resembling fibrolamellar hepatocellular carcinoma","volume":"153","author":"Engelholm","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib51","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41379-019-0398-2","article-title":"DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma","volume":"33","author":"Vyas","year":"2020","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib52","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.29719","article-title":"Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion","volume":"68","author":"Graham","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib53","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2017.07.009","article-title":"Molecular classification of hepatocellular adenoma in clinical practice","volume":"67","author":"Nault","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"35","key":"10.1016\/j.path.2020.09.002_bib54","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.3748\/wjg.v24.i35.3980","article-title":"Pediatric hepatocellular carcinoma","volume":"24","author":"Khanna","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MPG.0000000000002093","article-title":"Characteristics of hepatitis B virus-associated hepatocellular carcinoma in children: a multi-center study","volume":"67","author":"Mogul","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3\u20134","key":"10.1016\/j.path.2020.09.002_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000200995","article-title":"Budd-Chiari syndrome as the primary manifestation of a fibrolamellar hepatocellular carcinoma","volume":"53","author":"Lamberts","year":"1992","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1542\/peds.82.3.379","article-title":"Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver","volume":"82","author":"McCloskey","year":"1988","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MAJ.0b013e3181bccfb4","article-title":"Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma","volume":"338","author":"Sethi","year":"2009","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.semdp.2016.12.010","article-title":"Fibrolamellar carcinoma: a histologically unique tumor with unique molecular findings","volume":"34","author":"Graham","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib60","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1148\/radiol.2232010801","article-title":"Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria","volume":"223","author":"Blachar","year":"2002","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.path.2020.09.002_bib61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiology.157.3.2997835","article-title":"Fibrolamellar hepatocellular carcinoma","volume":"157","author":"Friedman","year":"1985","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.path.2020.09.002_bib62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/mpo.10178","article-title":"Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment","volume":"39","author":"Czauderna","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"10","key":"10.1016\/j.path.2020.09.002_bib63","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.2014.60.2250","article-title":"Hepatocellular carcinoma in children: does modified platinum- and doxorubicin-based chemotherapy increase tumor resectability and change outcome? lessons learned from the SIOPEL 2 and 3 Studies","volume":"34","author":"Murawski","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.09.002_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/lt.24994","article-title":"Survival of children after liver transplantation for hepatocellular carcinoma","volume":"24","author":"Baumann","year":"2018","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.path.2020.09.002_bib65","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2002.06.102","article-title":"Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group","volume":"20","author":"Czauderna","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.path.2020.09.002_bib66","doi-asserted-by":"crossref","first-page":"e13305","DOI":"10.1111\/petr.13305","article-title":"Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma","volume":"22","author":"Ezekian","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.path.2020.09.002_bib67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000354698","article-title":"Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma","volume":"85","author":"Kaseb","year":"2013","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.path.2020.09.002_bib68","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.11292","article-title":"Fibrolamellar hepatocellular carcinoma in children and adolescents","volume":"97","author":"Katzenstein","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.path.2020.09.002_bib69","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/petr.12144","article-title":"Surgical treatment of primary liver tumors in children: outcomes analysis of resection and transplantation in the SEER database","volume":"17","author":"McAteer","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"12","key":"10.1016\/j.path.2020.09.002_bib70","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.ejca.2013.04.012","article-title":"Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience","volume":"49","author":"Weeda","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.path.2020.09.002_bib71","article-title":"Surgical management of pediatric hepatocellular carcinoma: an analysis of the National Cancer Database","author":"Ziogas","year":"2020","journal-title":"J\u00a0Pediatr Surg"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib72","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.21703","article-title":"Outcome of patients with fibrolamellar hepatocellular carcinoma","volume":"106","author":"Stipa","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.path.2020.09.002_bib73","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s11605-016-3216-x","article-title":"Prognosis of fibrolamellar carcinoma compared to non-cirrhotic conventional hepatocellular carcinoma","volume":"20","author":"Yamashita","year":"2016","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.path.2020.09.002_bib74","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1399-3046.2007.00751.x","article-title":"Outcomes of transplantation in children with primary hepatic malignancy","volume":"11","author":"Beaunoyer","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"11","key":"10.1016\/j.path.2020.09.002_bib75","doi-asserted-by":"crossref","first-page":"e27293","DOI":"10.1002\/pbc.27293","article-title":"Surgical management of children and adolescents with upfront completely resected hepatocellular carcinoma","volume":"65","author":"D'Souza","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.path.2020.09.002_bib76","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.path.2020.09.002_bib77","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/17474124.2019.1621746","article-title":"Liver disease secondary to congenital heart disease in children","volume":"13","author":"Komatsu","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:54Z","timestamp":1761748854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918120300647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1875918120300647"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2020.09.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Liver Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}